1
|
Amari S, Karbab A, Charef N, Arrar L, Mubarak MS. Anti-urolithiatic, antibacterial, anti-inflammatory and analgesic effects of Erica arborea flowers and leaves hydromethanolic extracts: An ethnopharmacological study. Saudi J Biol Sci 2023; 30:103785. [PMID: 37680977 PMCID: PMC10480653 DOI: 10.1016/j.sjbs.2023.103785] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2023] [Revised: 07/31/2023] [Accepted: 08/11/2023] [Indexed: 09/09/2023] Open
Abstract
Erica arborea L. is a medicinal plant vastly used in therapeutic purposes in several parts of the world for antimicrobial, anti-inflammatory, and diuretic purposes, and in treating urinary infections and kidney stones. The current investigation aimed to evaluate the medicinal use of E. arborea in Algeria's Bejaia region, and to examine the anti-urolithiatic, antibacterial, anti-inflammatory (in vivo), analgesic, and toxicity effects of E. arborea hydromethanolic extracts from leaves (EALE) and flowers (EALE) to give a justification for its use in the traditional medicine. The in vitro anti-urolithiathic activity of E. arborea leaf and flower hydromethanolic extracts nucleation and aggregation of crystals were measured using spectrophotometric methods. The agar disk diffusion assay and minimum inhibitory concentration (MIC) determination were employed to estimate the antibacterial effect of EAME against three Gram-positive and three Gram-negative bacterial strains in vitro. In addition, the xylene and croton oil-induced ear edema methods in mice were used to examine the topical and oral anti-inflammatory potential of the extracts. Similarly, the analgesic effect of the extract was assessed via the acetic acid-induced abdominal constriction in mice, whereas the acute toxicity of EAME was conducted following OECD guidelines. An ethnobotanical survey was conducted among 171 informants with 212 questionnaire cards. Results indicated that 28.04 % of people in the studied region used E. arborea in traditional folk medicine. Additionally, results revealed the presence of epicatechin, palmitic acid, and kaempferol-3-O-glucoside in the plant extracts. Results also showed that EAME exhibits significant and dose-dependent anti-urolithiatic activity in nucleation and aggregation assays. Furthermore, results revealed that the extracts exhibit significant antibacterial activity. The E. arborea flower extract (EAFE) showed maximum antibacterial activity, especially against P. aeruginosa, E. coli, S. gallinarum, and B. cereus. In addition, a greater minimum inhibitory concentration (MIC) in this extract was found at 1.60 mg/mL against M. luteus strain compared to the positive control. Moreover, the EAME caused a significant inhibition influence in the xylene and croton oil-induced edematous in mice. In contrast, the topical anti-inflammatory potential showed that extracts exhibit a considerable anti-edematogenic effect in both animal models. In the writhing reaction induced by the acetic acid model, the two extracts significantly reduced abdominal contractions. Finally, results of the toxicity assay showed that EAME is safe and no deaths or changes in mice behavior were observed even when doses as high as 5 g/kg DW were used. From the ethnopharmacological studies, our consequences endorse the benefit of E. arborea in folk medicine. Results of this investigation suggest that the leaf and flower extracts of E. arborea exhibit notable anti-urolithiatic, anti-inflammatory, analgesic, and antibacterial activities and are safe as a natural source of drugs with the above effects.
Collapse
Affiliation(s)
- Salima Amari
- Laboratory of Applied Biochemistry, Faculty of Natural and Life Sciences, Ferhat Abbas University Setif1, 19000, Algeria
| | - Ahlem Karbab
- Laboratory of Applied Biochemistry, Faculty of Natural and Life Sciences, Ferhat Abbas University Setif1, 19000, Algeria
| | - Noureddine Charef
- Laboratory of Applied Biochemistry, Faculty of Natural and Life Sciences, Ferhat Abbas University Setif1, 19000, Algeria
| | - Lekhmici Arrar
- Laboratory of Applied Biochemistry, Faculty of Natural and Life Sciences, Ferhat Abbas University Setif1, 19000, Algeria
| | | |
Collapse
|
2
|
Sharma A, Mehta V, Rani S, Noda M, Sugiyama M, Chander H, Kaur B. Biomedical applications of L-alanine produced by Pediococcus acidilactici BD16 (alaD +). Appl Microbiol Biotechnol 2022. [PMID: 35089399 DOI: 10.1007/s00253-022-11766-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2021] [Revised: 12/01/2021] [Accepted: 01/06/2022] [Indexed: 11/02/2022]
Abstract
L-alanine possesses extensive physiological functionality and tremendous pharmacological significance, therefore could be considered as potential ingredient for food, pharmaceutical, and personal care products. However, therapeutic properties of L-alanine still need to be addressed in detail to further strengthen its utilization as a viable ingredient for developing natural therapeutics with minimum side effects. Thus, the present study was aimed to explore the anticipated therapeutic potential of L-alanine, produced microbially using a lactic acid bacterial strain Pediococcus acidilactici BD16 (alaD+) expressing L-alanine dehydrogenase enzyme. The anticipated therapeutic potential of L-alanine was assessed in terms of anti-proliferative, anti-bacterial, and anti-urolithiatic properties. Anti-bacterial assays revealed that L-alanine successfully inhibited growth and in vitro proliferation of important human pathogens including Enterococcus faecalis, Escherichia coli, Klebsiella pneumonia, Staphylococcus aureus, Streptococcus mutans, and Vibrio cholerae in a concentration-dependent manner. Current investigation has also revealed its significant anti-proliferative potential against human lung adenocarcinoma (A549; IC50 7.32 μM) and mammary gland adenocarcinoma (MCF-7; IC50 8.81 μM) cells. The anti-urolithiatic potential of L-alanine was augmented over three different phases, viz., nucleation inhibition, aggregation inhibition, and oxalate depletion. Further, an in vitro cell culture-based kidney stone dissolution model using HEK293-T cells was also established to further strengthen its anti-urolithiatic potential. This is probably the first in vitro cell culture-based model which experimentally validates the immense therapeutic efficacy of L-alanine in treating urolithiasis disease. KEY POINTS: • Assessment of therapeutic potential of L-alanine produced by LAB. • L-alanine exhibited significant anti-proliferative and anti-bacterial activities. • L-alanine as potential anti-urolithiatic agent.
Collapse
|
3
|
Salem PPO, Vieira NB, Garcia DA, Nicácio KJ, Dias DF, de Paula ACC, Assis DM, Caldas IS, Novaes RD, Marinho MV, Rosa IML, Soares MG, Chagas-Paula DA. Anti-urolithiatic and anti-inflammatory activities through a different mechanism of actions of Cissus gongylodes corroborated its ethnopharmacological historic. J Ethnopharmacol 2020; 253:112655. [PMID: 32045681 DOI: 10.1016/j.jep.2020.112655] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/06/2019] [Revised: 02/02/2020] [Accepted: 02/04/2020] [Indexed: 06/10/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Species Cissus gongylodes has been used in the traditional medicine in South America and India for the treatment of urolithiasis, biliary and inflammatory problems without any scientific evidence. AIM OF THE STUDY This work was developed to investigate for the first time the anti-inflammatory and anti-urolithiatic activities of leaf decoction of C. gongylodes. MATERIALS AND METHODS Decoction was subjected to anti-inflammatory evaluation by the in vivo assay of ear oedema and quantification of the main mediators of inflammation PGE2 and LTB4, and the cytokine TNF-α. The decoction's anti-urolithiatic activity was determined by different in vitro assays to evaluate the inhibition and dissolution of the most prevalent types of kidney stones: calcium oxalate (CaOx) and struvite. Diffusion in gel technique and fresh urine of a patient with renal stone were used to investigate the inhibition and dissolution of CaOx, respectively, and the single diffusion gel growth technique was used to evaluate the inhibition and dissolution of struvite crystals. The decoction was chemically characterized by UHPLC-ESI-HRMS analysis. RESULTS Decoction showed in vivo anti-inflammatory activity by potent decreasing the level of both the main mediators of inflammation and dose-dependent in vitro anti-urolithiatic action by inhibition and dissolution of both type of crystals, CaOx and struvite. CONCLUSIONS Results obtained corroborate the reports of the traditional use of the decoction of Cissus gongylodes. Besides, it showed multi-target mechanisms actions, inhibition of the main inflammatory pathways, and inhibition/dissolution of the most prevalent types of crystals on urolithiasis. These actions make the decoction a promissory source to the development of new and more efficient drugs.
Collapse
Affiliation(s)
- Paula P O Salem
- Laboratory of Phytochemistry and Medicinal Chemistry, Chemistry Institute, Federal University of Alfenas (UNIFAL-MG), Rua Gabriel Monteiro da Silva, 700, 37130-001, Alfenas, Minas Gerais, Brazil
| | - Nátalie B Vieira
- Laboratory of Phytochemistry and Medicinal Chemistry, Chemistry Institute, Federal University of Alfenas (UNIFAL-MG), Rua Gabriel Monteiro da Silva, 700, 37130-001, Alfenas, Minas Gerais, Brazil
| | - Daniela A Garcia
- Laboratory of Phytochemistry and Medicinal Chemistry, Chemistry Institute, Federal University of Alfenas (UNIFAL-MG), Rua Gabriel Monteiro da Silva, 700, 37130-001, Alfenas, Minas Gerais, Brazil
| | - Karen J Nicácio
- Laboratory of Phytochemistry and Medicinal Chemistry, Chemistry Institute, Federal University of Alfenas (UNIFAL-MG), Rua Gabriel Monteiro da Silva, 700, 37130-001, Alfenas, Minas Gerais, Brazil
| | - Danielle F Dias
- Laboratory of Phytochemistry and Medicinal Chemistry, Chemistry Institute, Federal University of Alfenas (UNIFAL-MG), Rua Gabriel Monteiro da Silva, 700, 37130-001, Alfenas, Minas Gerais, Brazil
| | - Ana C C de Paula
- Department of Pharmaceutical Sciences, Federal University of Juiz de Fora (UFJF), Rua José Lourenço Kelmer, s/n, 36036-900, Juiz de Fora, Minas Gerais, Brazil
| | - Diego M Assis
- Bruker do Brasil, Condomínio Barão de Mauá, Rod. Dom Pedro I, km 87.5, 12954-260, Atibaia, São Paulo, Brazil
| | - Ivo S Caldas
- Department of Pathology and Parasitology, Institute of Biomedical Sciences, Federal University of Alfenas (UNIFAL-MG), Rua Gabriel Monteiro da Silva, 700, 37130-001, Alfenas, Minas Gerais, Brazil
| | - Romulo D Novaes
- Department of Structural Biology, Institute of Biomedical Sciences, Federal University of Alfenas (UNIFAL-MG), Rua Gabriel Monteiro da Silva, 700, 37130-001, Alfenas, Minas Gerais, Brazil
| | - Maria V Marinho
- Chemistry Institute, Federal University of Alfenas (UNIFAL-MG), Avenida Jovino Fernandes Sales, 2600, Campus Santa Clara, 37133-840, Alfenas, Minas Gerais, Brazil
| | - Iara M L Rosa
- Chemistry Institute, Federal University of Alfenas (UNIFAL-MG), Avenida Jovino Fernandes Sales, 2600, Campus Santa Clara, 37133-840, Alfenas, Minas Gerais, Brazil
| | - Marisi G Soares
- Laboratory of Phytochemistry and Medicinal Chemistry, Chemistry Institute, Federal University of Alfenas (UNIFAL-MG), Rua Gabriel Monteiro da Silva, 700, 37130-001, Alfenas, Minas Gerais, Brazil
| | - Daniela A Chagas-Paula
- Laboratory of Phytochemistry and Medicinal Chemistry, Chemistry Institute, Federal University of Alfenas (UNIFAL-MG), Rua Gabriel Monteiro da Silva, 700, 37130-001, Alfenas, Minas Gerais, Brazil.
| |
Collapse
|